calcium gluconate · Fresenius Kabi Usa · NDA 208418, 210906
Calcium Gluconate
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 208418-00117 Sep 2026
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 208418 · 001 · RLD | solution, intravenous | 1GM/10ML (100MG/ML) | open |
| 208418 · 002 · RLD | solution, intravenous | 5GM/50ML (100MG/ML) | open |
| 208418 · 003 · RLD | solution, intravenous | 10GM/100ML (100MG/ML) | open |
| 210906 · 004 · RLD | solution, intravenous | 10GM/100ML (100MG/ML) | open |